Estrogens and Endometrial Cancer

FDA Drug Bulletin 6 (3); 1976.

Cramer DW Cutler SJ Christine B. Trends in the incidence of endometrial cancer in the United States. Gynecol Oncol 1974; 2: 130–43.

McDonald TW Annegers JF O'Fallon WM Dockerty MB Malkasian GD Kurland LT , Exogenous estrogen and endometrial carcinoma: Case-control and incidence study. Am J Obstet Gynecol 1971; 127: 572–80.

Weiss MD Szekely DR Austin DF , Increasing incidence of endometrial cancer in the United States. N Engl J Med 1976; 294: 1259–62.

Greenwald P Caputo TA Wolfgang PE , Endometrial cancer after menopausal use of estrogens. Obstet Gynecol 1977; 50 (2): 239–43.

Walker AM Jick H. Cancer of the corpus uteri: Increasing incidence in the United States. 1970–1975. (unpublished, 1978).

Wigle DT Grace M Smith SO , Estrogen use and cancer of the uterine corpus in Alberta. Can Med Assoc J 1978; 118: 1276–8.

Jick H Watkins RN Hunter JR , Replacement estrogens and endometrial cancer. N Engl J Med 1979; 300: 218–22.

National Prescription Audit. Ambler, PA: IMS America.

Stadel BV Weiss NS , Characteristics of menopausal women: A survey of King and Pierce counties in Washington, 1973–1974. Am J Epidemiol 1975; 102: 209–16.

Smith DC Prentice R Thompson DJ Herrmann W. Association of exogenous estrogens and endometrial carcinoma. N Engl J Med 1975; 293: 1165–7.

Ziel HK Finkle WD , Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 1975; 293: 1167–70.

Rosenberg L Shapiro S Kaufman D Slone D Miettinen O Stolley P. Patterns and determinants of conjugated estrogen use. Am J Epidemiol 1979; 109: 676–86.

Knab DR , Estrogen and endometrial carcinoma. Obstet Gynecol Surv 1977; 32: 267–81.

Ng AB Reagan JW , Incidence and prognosis of endometrial carcinoma by histologic grade and extent. Obstet Gynecol 1970; 35: 437–43.

MacMahon B. Risk factors for endometrial cancer. Gynecol Oncol 1974; 2: 122–9.

Jensen EI Denmark V Ostergaard E. Clinical studies concerning the relationship of estrogens to the development of cancer of the corpus uteri. Am J Obstet Gynecol 1954; 67: 1094–1102.

Wynder EL Escher GC Mantel N. An epidemiological investigation of cancer of the endometrium. Cancer 1966; 19: 489–520.

Dunn LJ Bradbury JR , Endocrine factors in endometrial carcinoma. Am J Obstet Gynecol 1967; 97: 465–71.

Pacheco JC Kempers KD , Etiology of postmenopausal bleeding. Obstet Gynecol 1968; 32: 40–6.

Mack TM Pike MC Henderson BE , Estrogens and endometrial cancer in a retirement community. N Engl J Med 1976; 294: 1262–7.

Gray LA Christopherson WM Hoover RN , Estrogens and endometrial carcinoma. Obstet Gynecol 1977; 49: 385–9.

Horwitz RI Feinstein AR , Alternative analytic methods for case-control studies of estrogens and endometrial cancer. N Engl J Med 1978; 299: 1089–94.

Antunes CM Stolley PD Rosenshein ND , Endometrial cancer and estrogen use. N Engl J Med 1979; 300: 9–13. 9–13.

Gordan GS Greenberg BG , Exogenous estrogens and endometrial cancer. Postgrad Med 1976; 59 (6): 66–77.

Kistner RW , Estrogens and endometrial cancer. Obstet Gynecol 1976; 48: 479–82.

Feinstein AR Horwitz RJ , A critique of the statistical evidence associating estrogens with endometrial cancer. Cancer Res 1978; 38: 4001–5.

Hulka BS Hogue CJ Greenberg BG , Methodologic issues in epidemiologic studies of endometrial cancer and exogenous estrogen. Am J Epidemiol 1978; 107: 267–76.

Gordon J Reagan JW Finkle WD Ziel HK , Estrogen and endometrial carcinoma. N Engl J Med 1977; 297: 570–1.